BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37337205)

  • 1. The adherence to and utility of the Global Initiative for Chronic Obstructive Lung Disease guidelines for treating COPD among pulmonary specialists: a retrospective analysis.
    Alabi FO; Alkhateeb HA; Zibanayi MT; Garces J; DeBarros KM; Barletti PSB; Garcia K; James RK
    BMC Pulm Med; 2023 Jun; 23(1):216. PubMed ID: 37337205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.
    Brusselle G; Price D; Gruffydd-Jones K; Miravitlles M; Keininger DL; Stewart R; Baldwin M; Jones RC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2207-17. PubMed ID: 26527869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
    Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States.
    Schabert V; Shah S; Holmgren U; Cabrera C
    Ther Adv Respir Dis; 2021; 15():17534666211001018. PubMed ID: 33866875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study.
    Hsieh MJ; Huang SY; Yang TM; Tao CW; Cheng SL; Lee CH; Kuo PH; Wu YK; Chen NH; Hsu WH; Hsu JY; Lin MS; Wang CC; Wei YF; Tsai YH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2949-2959. PubMed ID: 30310271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD patients' characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study.
    Tsiligianni I; Kampouraki M; Ierodiakonou D; Poulonirakis I; Papadokostakis P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():547-556. PubMed ID: 30880944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve.
    Rajnoveanu RM; Rajnoveanu AG; Ardelean AB; Todea DA; Pop CM; Antoniu SA; Motoc NS; Chis AF; Fildan AP; Man MA
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32825456
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
    Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.
    Price D; Miravitlles M; Pavord I; Thomas M; Wedzicha J; Haughney J; Bichel K; West D
    NPJ Prim Care Respir Med; 2016 Nov; 26():16061. PubMed ID: 27808096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
    Ding B; Small M; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014.
    Visentin E; Nieri D; Vagaggini B; Peruzzi E; Paggiaro P
    Curr Med Res Opin; 2016 Sep; 32(9):1493-502. PubMed ID: 27215310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
    Ivanov Y; Nikolaev I; Nemeth I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J; Dik N; Bugden S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.
    Sulku J; Janson C; Melhus H; Malinovschi A; Ställberg B; Bröms K; Högman M; Lisspers K; Hammarlund-Udenaes M; Nielsen EI
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2451-2460. PubMed ID: 31806954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
    Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD - subgroup analysis of the Taiwan obstructive lung disease cohort.
    Wei YF; Kuo PH; Tsai YH; Tao CW; Cheng SL; Lee CH; Wu YK; Chen NH; Hsu WH; Hsu JY; Lin MS; Wang CC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1951-6. PubMed ID: 26392770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
    Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
    Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.